{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T08:55:49Z","timestamp":1794128149104,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.dsx.2023.102782","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T12:34:01Z","timestamp":1684758841000},"page":"102782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of more versus less intensive blood pressure control on cardiovascular, renal and mortality outcomes in people with type 2 diabetes: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"17","author":[{"given":"Ekaterini","family":"Ioannidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmin","family":"Shabnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Abner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zaccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Seidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8417-9700","authenticated-orcid":false,"given":"Clare L.","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2023.102782_bib1","series-title":"IDF diabetes atlas","author":"International","year":"2021"},{"issue":"1","key":"10.1016\/j.dsx.2023.102782_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-016-0485-3","article-title":"Blood pressure control in type 2 diabetic patients","volume":"16","author":"Grossman","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.dsx.2023.102782_bib3","unstructured":"Recommendations | Hypertension in adults: diagnosis and management | Guidance | NICE. https:\/\/www.nice.org.uk\/guidance\/ng136\/chapter\/recommendations. Accessed September 9, 2021."},{"key":"10.1016\/j.dsx.2023.102782_bib4","doi-asserted-by":"crossref","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC. J Hypertens. 25:1105\u20131187.","DOI":"10.1097\/HJH.0b013e3281fc975a"},{"issue":"17","key":"10.1016\/j.dsx.2023.102782_bib5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archinternmed.2012.3147","article-title":"Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis","volume":"172","author":"McBrien","year":"2012","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.dsx.2023.102782_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes : a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA, J Am Med Assoc"},{"issue":"10017","key":"10.1016\/j.dsx.2023.102782_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.dsx.2023.102782_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215362","article-title":"Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: a meta-analysis","volume":"14","author":"Wang","year":"2019","journal-title":"PLoS One"},{"issue":"10285","key":"10.1016\/j.dsx.2023.102782_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"The Blood Pressure Lowering Treatment Trialists' Collaboration, Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-ana","volume":"397","author":"Rahimi","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.dsx.2023.102782_bib10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Academia and clinic annals of internal medicine preferred reporting Items for systematic reviews and meta-analyses","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dsx.2023.102782_bib11","doi-asserted-by":"crossref","unstructured":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. doi:10.1136\/bmj.d5928.","DOI":"10.1136\/bmj.d5928"},{"key":"10.1016\/j.dsx.2023.102782_bib12","series-title":"Methods for meta-analysis in medical research","author":"Sutton","year":"2000"},{"issue":"7160","key":"10.1016\/j.dsx.2023.102782_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"Turner","year":"1998","journal-title":"Br Med J"},{"issue":"7650","key":"10.1016\/j.dsx.2023.102782_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Br Med J"},{"key":"10.1016\/j.dsx.2023.102782_bib15","author":"Stata"},{"issue":"17","key":"10.1016\/j.dsx.2023.102782_bib16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.dsx.2023.102782_bib17","article-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes","volume":"23","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.dsx.2023.102782_bib18","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.amjhyper.2006.05.011","article-title":"Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes","volume":"19","author":"Estacio","year":"2006","journal-title":"Am J Hypertens"},{"issue":"12","key":"10.1016\/j.dsx.2023.102782_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-8587(17)30327-3","article-title":"Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial","volume":"5","author":"Ueki","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.dsx.2023.102782_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.ogx.0000320471.93857.21","article-title":"Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial","volume":"63","author":"Hb","year":"2008","journal-title":"Obstet Gynecol Surv"},{"issue":"1","key":"10.1016\/j.dsx.2023.102782_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.107468","article-title":"Intensive multifactorial intervention improved renal impairment in short-duration type 2 diabetes: a randomized, controlled, 7-year follow-up trial","volume":"34","author":"Shi","year":"2020","journal-title":"J\u00a0Diabet Complicat"},{"issue":"3","key":"10.1016\/j.dsx.2023.102782_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3111","article-title":"Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5-year and longer-term modelled outcomes of the ADDITION-Leicester study","volume":"35","author":"Webb","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"issue":"9118","key":"10.1016\/j.dsx.2023.102782_bib23","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.dsx.2023.102782_bib24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.dsx.2023.102782_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/M20-2037","article-title":"Effect of intensive blood pressure lowering on cardiovascular outcomes: a systematic review prepared for the 2020 U.S. Department of veterans affairs\/U.S. Department of defense guidelines","volume":"173","author":"D'Anci","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dsx.2023.102782_bib26","author":"Benavente"},{"issue":"12","key":"10.1016\/j.dsx.2023.102782_bib27","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1291\/hypres.31.2115","article-title":"Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS","volume":"31","author":"Group","year":"2008","journal-title":"Hypertens Res"},{"issue":"2","key":"10.1016\/j.dsx.2023.102782_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.146035","article-title":"Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in elderly isolated systolic hypertension study","volume":"56","author":"Ogihara","year":"2010","journal-title":"Hypertension"},{"issue":"22","key":"10.1016\/j.dsx.2023.102782_bib29","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.dsx.2023.102782_bib30","first-page":"2565","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"9463","key":"10.1016\/j.dsx.2023.102782_bib31","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402123000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402123000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:22:58Z","timestamp":1761729778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402123000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1871402123000784"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2023.102782","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of more versus less intensive blood pressure control on cardiovascular, renal and mortality outcomes in people with type 2 diabetes: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2023.102782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC).","name":"copyright","label":"Copyright"}],"article-number":"102782"}}